微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.66% | 22% | -15.47% | 24/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.33% | 233.64% | -39.01% | 64/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 7.1% | 394.61% | 118.46% | 48/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.25% | 151.1% | 8.33% | 58/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3% | 889.47% | 192.59% | 36/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -3.24% | 86.54% | -34.44% | 113/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -2.41% | 39.75% | 62.11% | 122/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -6.36% | 10.3% | -1573.68% | 130/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -0.38% | -46.15% | 98.42% | 122/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -24.08% | -15.94% | -502% | 137/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -4% | -406.33% | 43.58% | 122/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -7.09% | -79.49% | -2626.92% | 136/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.26% | -273.33% | 98.75% | 116/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -20.77% | 48.09% | -2529.11% | 135/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -0.79% | 95.19% | 80% | 116/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -3.95% | 65.29% | -2733.33% | 126/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.15% | 102.73% | 100.37% | 109/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -40.01% | -448.83% | -143.81% | 138/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -16.41% | -408.46% | -44.2% | 113/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -11.38% | -1238% | -106.91% | 125/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -5.5% | -323.58% | 24.55% | 109/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -7.29% | -331.36% | -237.03% | 121/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.32% | 99.25% | 432% | 63/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1% | -41.86% | -59.35% | 98/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.46% | 176.4% | 245.56% | 44/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -1.69% | -522.5% | -163.3% | 122/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.67% | -9.18% | 55.23% | 86/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.72% | -27.43% | 93.26% | 86/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.89% | 12.66% | 122.5% | 80/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.4% | -48.72% | -86.39% | 117/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.94% | -19.45% | 24.05% | 79/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.37% | -2.47% | 200% | 78/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.79% | -5.95% | 1.28% | 67/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.78% | -74.26% | -78.63% | 100/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.65% | -17.98% | 50.21% | 63/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.43% | -14.13% | 189.29% | 62/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.84% | -24.32% | -72.28% | 59/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 3.03% | -47.3% | -31.91% | 81/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 4.45% | -4.3% | 57.24% | 51/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 2.83% | -1.39% | 154.96% | 55/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.11% | 2.78% | -80.7% | 48/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |